Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab
Kulachanya Suwanwongse, Nehad Shabarek
Topics & Concepts
MedicineOcrelizumabMultiple sclerosisCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DermatologyInternal medicineVirologyImmunologyInfectious disease (medical specialty)LymphomaDiseaseRituximabOutbreakPeripheral Neuropathies and DisordersMultiple Sclerosis Research StudiesLong-Term Effects of COVID-19